Giant Biogene Holding Co., Ltd.'s (HKG:2367) Chief Scientific Officer Daidi Fan is the most upbeat insider, and their holdings increased by 3.3% last week

Simply Wall St.12-19

Key Insights Giant Biogene Holding's significant insider ownership suggests inherent interests in company's expansion 58% of the company is held by a single shareholder (Daidi Fan) Institutions ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2492787321?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278","is_english":true,"pubTime":"2024-12-19 13:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2492787321","market":"us","top_or_hot":-1,"title":"Giant Biogene Holding Co., Ltd.'s (HKG:2367) Chief Scientific Officer Daidi Fan is the most upbeat insider, and their holdings increased by 3.3% last week","media":"Simply Wall St.","content":"<div>\n<p>Key Insights  Giant Biogene Holding's significant insider ownership suggests inherent interests in company's expansion   58% of the company is held by a single shareholder (Daidi Fan)    Institutions ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/household/hkg-2367/giant-biogene-holding-shares/news/giant-biogene-holding-co-ltds-hkg2367-chief-scientific-offic\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Giant Biogene Holding Co., Ltd.'s (HKG:2367) Chief Scientific Officer Daidi Fan is the most upbeat insider, and their holdings increased by 3.3% last week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGiant Biogene Holding Co., Ltd.'s (HKG:2367) Chief Scientific Officer Daidi Fan is the most upbeat insider, and their holdings increased by 3.3% last week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-19 13:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/household/hkg-2367/giant-biogene-holding-shares/news/giant-biogene-holding-co-ltds-hkg2367-chief-scientific-offic><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Key Insights  Giant Biogene Holding's significant insider ownership suggests inherent interests in company's expansion   58% of the company is held by a single shareholder (Daidi Fan)    Institutions ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/household/hkg-2367/giant-biogene-holding-shares/news/giant-biogene-holding-co-ltds-hkg2367-chief-scientific-offic\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02367","symbol_name":"巨子生物","start_time":0,"source_url":"https://simplywall.st/stocks/hk/household/hkg-2367/giant-biogene-holding-shares/news/giant-biogene-holding-co-ltds-hkg2367-chief-scientific-offic","article_id":"2492787321","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492787321","pubTimestamp":1734586931,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Key Insights Giant Biogene Holding's significant insider ownership suggests inherent interests in company's expansion...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"02367":"巨子生物","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","BK1207":"个人用品"},"translate_title":"巨人生物基因控股有限公司（HKG：2367）首席科学官Daidi Fan是最乐观的内部人士，他们上周增持了3.3%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02367":1},"content_text":"Key Insights  Giant Biogene Holding's significant insider ownership suggests inherent interests in company's expansion   58% of the company is held by a single shareholder (Daidi Fan)    Institutions own 18% of Giant Biogene Holding   To get a sense of who is truly in control of Giant Biogene Holding Co., Ltd. (HKG:2367), it is important to understand the ownership structure of the business.  We can see that individual insiders own the lion's share in the company with 58% ownership.   In other words, the group stands to gain the most (or lose the most) from their investment into the company.  As a result, insiders scored the highest last week as the company hit HK$52b market cap following a 3.3% gain in the stock.     In the chart below, we zoom in on the different ownership groups of Giant Biogene Holding.  Check out our latest analysis for Giant Biogene Holding SEHK:2367 Ownership Breakdown December 19th 2024 What Does The Institutional Ownership Tell Us About Giant Biogene Holding? Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.   Giant Biogene Holding already has institutions on the share registry. Indeed, they own a respectable stake in the company.  This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong.  It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Giant Biogene Holding, (below). Of course, keep in mind that there are other factors to consider, too. SEHK:2367 Earnings and Revenue Growth December 19th 2024  Hedge funds don't have many shares in Giant Biogene Holding.      Because actions speak louder than words, we consider it a good sign when insiders own a significant stake in a company. In Giant Biogene Holding's case, its Chief Scientific Officer, Daidi Fan, is the largest shareholder, holding 58% of shares outstanding.       With 5.0% and 1.8% of the shares outstanding respectively, E Fund Management Co., Ltd. and The Vanguard Group, Inc. are the second and third largest shareholders.    Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments.   Quite a few analysts cover the stock, so you could look into forecast growth quite easily.  Insider Ownership Of Giant Biogene Holding The definition of an insider can differ slightly between different countries, but members of the board of directors always count.  Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.  Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.   It seems that insiders own more than half the Giant Biogene Holding Co., Ltd. stock. This gives them a lot of power.   Given it has a market cap of HK$52b, that means insiders have a whopping HK$30b worth of shares in their own names.  Most would be pleased to see the board is investing alongside them. You may wish to discover if they have been buying or selling.   General Public Ownership The general public, who are usually individual investors, hold a 24% stake in Giant Biogene Holding.   While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.  Next Steps: While it is well worth considering the different groups that own a company, there are other factors that are even more important.    Take risks for example - Giant Biogene Holding has   1 warning sign   we think you should be aware of.     If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.  NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2492787321"}